Brief: Point Biopharma Reports Second Quarter 2023 Financial Results And Provides Business Highlights

POINT Biopharma Global

14/08/2023 12:40

Aug 14 (Reuters) - Point Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA REPORTS SECOND QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS HIGHLIGHTS
    * POINT BIOPHARMA - AS OF JUNE 30, 2023, CO HAD ABOUT $434.8
MILLION IN CASH, CASH EQUIVALENTS, & INVESTMENTS, ANTICIPATED TO
FUND OPERATIONS INTO 2026
    * QTRLY LOSS PER SHARE $0.24
    * Q2 EARNINGS PER SHARE VIEW $-0.29 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbY70ZR 
Further company coverage:  PNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))